Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: yes.
Hackam
Daniel G
DG
Department of Medicine, Division of Clinical Neurological Sciences, University of Western Ontario, Ontario, Canada. dhackam@uwo.ca
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D002986:Clinical Trials as Topic; D006801:Humans; D020521:Stroke / Q000517:prevention & control*
D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists